ACTG Network Monthly Newsletter - August 2016

Date: 08/30/2016

Publication:

ACTG

Women's Outreach Workers Project Releases New Educational Video


New Video Addresses Questions Women and Minorities May Have Regarding ACTG Network Clinical Trials

The Women's Outreach Workers (WOW) Project was established with the goal of developing optimal strategies for increasing recruitment and retention of women, particularly women of color in ACTG Network clinical trials. Led by Susan E. Cohn, MD, MPH, Investigator at our Northwestern University Site, and working in collaboration with the Women's Health Inter-Network Scientific Committee (WHISC) and the Underrepresented Populations Committee (UPC), the WOW Project team created an educational video to help to answer many questions women and minorities may have about participating in ACTG Network clinical trials.


Click HERE for the rest of the article and to view the video.

Clinical Trials

P2001 (DAIDS ID 12026): Evaluating the Pharmacokinetics,...

TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...

Read More

A5282: A Randomized, Phase II Trial to Compare an HPV...

The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...

Read More

A5290, A Randomized, Phase 2b Study of a Double-Dose...

Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...

Read More

A5342: Evaluating the Safety, Tolerability, and Effect of a...

The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...

Read More

P1078: A Phase IV Randomized Double-Blind Placebo-Controlled...

P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...

Read More